303 related articles for article (PubMed ID: 18094416)
1. Gene expression-based molecular diagnostic system for malignant gliomas is superior to histological diagnosis.
Shirahata M; Iwao-Koizumi K; Saito S; Ueno N; Oda M; Hashimoto N; Takahashi JA; Kato K
Clin Cancer Res; 2007 Dec; 13(24):7341-56. PubMed ID: 18094416
[TBL] [Abstract][Full Text] [Related]
2. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
Nutt CL; Mani DR; Betensky RA; Tamayo P; Cairncross JG; Ladd C; Pohl U; Hartmann C; McLaughlin ME; Batchelor TT; Black PM; von Deimling A; Pomeroy SL; Golub TR; Louis DN
Cancer Res; 2003 Apr; 63(7):1602-7. PubMed ID: 12670911
[TBL] [Abstract][Full Text] [Related]
3. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.
Reddy SP; Britto R; Vinnakota K; Aparna H; Sreepathi HK; Thota B; Kumari A; Shilpa BM; Vrinda M; Umesh S; Samuel C; Shetty M; Tandon A; Pandey P; Hegde S; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Kondaiah P; Somasundaram K; Rao MR
Clin Cancer Res; 2008 May; 14(10):2978-87. PubMed ID: 18483363
[TBL] [Abstract][Full Text] [Related]
4. Molecular voting for glioma classification reflecting heterogeneity in the continuum of cancer progression.
Fuller GN; Mircean C; Tabus I; Taylor E; Sawaya R; Bruner JM; Shmulevich I; Zhang W
Oncol Rep; 2005 Sep; 14(3):651-6. PubMed ID: 16077969
[TBL] [Abstract][Full Text] [Related]
5. Identification of histological markers for malignant glioma by genome-wide expression analysis: dynein, alpha-PIX and sorcin.
Yokota T; Kouno J; Adachi K; Takahashi H; Teramoto A; Matsumoto K; Sugisaki Y; Onda M; Tsunoda T
Acta Neuropathol; 2006 Jan; 111(1):29-38. PubMed ID: 16320026
[TBL] [Abstract][Full Text] [Related]
6. Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival.
Ernst A; Hofmann S; Ahmadi R; Becker N; Korshunov A; Engel F; Hartmann C; Felsberg J; Sabel M; Peterziel H; Durchdewald M; Hess J; Barbus S; Campos B; Starzinski-Powitz A; Unterberg A; Reifenberger G; Lichter P; Herold-Mende C; Radlwimmer B
Clin Cancer Res; 2009 Nov; 15(21):6541-50. PubMed ID: 19861460
[TBL] [Abstract][Full Text] [Related]
7. Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes.
Godard S; Getz G; Delorenzi M; Farmer P; Kobayashi H; Desbaillets I; Nozaki M; Diserens AC; Hamou MF; Dietrich PY; Regli L; Janzer RC; Bucher P; Stupp R; de Tribolet N; Domany E; Hegi ME
Cancer Res; 2003 Oct; 63(20):6613-25. PubMed ID: 14583454
[TBL] [Abstract][Full Text] [Related]
8. Mathematical modeling of noise and discovery of genetic expression classes in gliomas.
Fathallah-Shaykh HM; Rigen M; Zhao LJ; Bansal K; He B; Engelhard HH; Cerullo L; Roenn KV; Byrne R; Munoz L; Rosseau GL; Glick R; Lichtor T; DiSavino E
Oncogene; 2002 Oct; 21(47):7164-74. PubMed ID: 12370806
[TBL] [Abstract][Full Text] [Related]
9. Automated brain tumor biopsy prediction using single-labeling cDNA microarrays-based gene expression profiling.
Castells X; García-Gómez JM; Navarro A; Acebes JJ; Godino O; Boluda S; Barceló A; Robles M; Ariño J; Arús C
Diagn Mol Pathol; 2009 Dec; 18(4):206-18. PubMed ID: 19861896
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.
Gravendeel LA; Kouwenhoven MC; Gevaert O; de Rooi JJ; Stubbs AP; Duijm JE; Daemen A; Bleeker FE; Bralten LB; Kloosterhof NK; De Moor B; Eilers PH; van der Spek PJ; Kros JM; Sillevis Smitt PA; van den Bent MJ; French PJ
Cancer Res; 2009 Dec; 69(23):9065-72. PubMed ID: 19920198
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of gliomas strongly predicts survival.
Freije WA; Castro-Vargas FE; Fang Z; Horvath S; Cloughesy T; Liau LM; Mischel PS; Nelson SF
Cancer Res; 2004 Sep; 64(18):6503-10. PubMed ID: 15374961
[TBL] [Abstract][Full Text] [Related]
12. Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: a preliminary feasibility study.
Marko NF; Toms SA; Barnett GH; Weil R
Genomics; 2008 May; 91(5):395-406. PubMed ID: 18343632
[TBL] [Abstract][Full Text] [Related]
13. Comparison of microarray and sage techniques in gene expression analysis of human glioblastoma.
Kavsan VM; Dmitrenko VV; Shostak KO; Bukreieva TV; Vitak NY; Simirenko OE; Malisheva TA; Shamayev MI; Rozumenko VD; Zozulya YA
Tsitol Genet; 2007; 41(1):36-55. PubMed ID: 17427416
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profile as a prognostic factor in high-grade gliomas.
Czernicki T; Zegarska J; Paczek L; Cukrowska B; Grajkowska W; Zajaczkowska A; Brudzewski K; Ulaczyk J; Marchel A
Int J Oncol; 2007 Jan; 30(1):55-64. PubMed ID: 17143512
[TBL] [Abstract][Full Text] [Related]
15. Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme.
Ruano Y; Mollejo M; Camacho FI; Rodríguez de Lope A; Fiaño C; Ribalta T; Martínez P; Hernández-Moneo JL; Meléndez B
Cancer; 2008 Apr; 112(7):1575-84. PubMed ID: 18260157
[TBL] [Abstract][Full Text] [Related]
16. MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance.
Guan Y; Mizoguchi M; Yoshimoto K; Hata N; Shono T; Suzuki SO; Araki Y; Kuga D; Nakamizo A; Amano T; Ma X; Hayashi K; Sasaki T
Clin Cancer Res; 2010 Aug; 16(16):4289-97. PubMed ID: 20601442
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling with oligonucleotide microarrays distinguishes World Health Organization grade of oligodendrogliomas.
Watson MA; Perry A; Budhraja V; Hicks C; Shannon WD; Rich KM
Cancer Res; 2001 Mar; 61(5):1825-9. PubMed ID: 11280731
[TBL] [Abstract][Full Text] [Related]
18. Outcome-based profiling of astrocytic tumours identifies prognostic gene expression signatures which link molecular and morphology-based pathology.
Beetz C; Bergner S; Brodoehl S; Brodhun M; Ewald C; Kalff R; Krüger J; Patt S; Kiehntopf M; Deufel T
Int J Oncol; 2006 Nov; 29(5):1183-91. PubMed ID: 17016650
[TBL] [Abstract][Full Text] [Related]
19. Translating expression profiling into a clinically feasible test to predict neuroblastoma outcome.
Schramm A; Vandesompele J; Schulte JH; Dreesmann S; Kaderali L; Brors B; Eils R; Speleman F; Eggert A
Clin Cancer Res; 2007 Mar; 13(5):1459-65. PubMed ID: 17332289
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling and subgroup identification of oligodendrogliomas.
Huang H; Okamoto Y; Yokoo H; Heppner FL; Vital A; Fevre-Montange M; Jouvet A; Yonekawa Y; Lazaridis EN; Kleihues P; Ohgaki H
Oncogene; 2004 Aug; 23(35):6012-22. PubMed ID: 15208679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
